Pfizer on Friday asked the FDA for an amendment to its emergency use authorization of its Covid-19 vaccine to expand its use in people ages 12-15 in the United States.
Pfizer on Friday asked the FDA for an amendment to its emergency use authorization of its Covid-19 vaccine to expand its use in people ages 12-15 in the United States.
